National Institute on Drug Abuse; Notice of Closed Meeting, 73017-73018 [05-23800]

Download as PDF Federal Register / Vol. 70, No. 235 / Thursday, December 8, 2005 / Notices provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Research Program Projects. Date: December 6, 2005. Time: 9 a.m to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Helen Lin, Ph.D., Scientific Review Administrator, NIH/ NIAMS/RB, 6701 Democracy Blvd., Suite 800, Plaza One, Bethesda, MD 20817. 301– 594–4952. linh1@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Emphasis Panel Mentored Patient-Oriented Research Career Development Award (K23). Date: December 15, 2005. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: NIEHS/National Institutes of Health, Building 4401, East Campus, 79 T.W. Alexander Drive, Research Triangle Park, NC 27709. (Telephone Conference Call). Contact Person: Linda K. Bass, PhD, Scientific Review Administrator, Nat’l Institutes of Environmental Health Sciences, P.O. Box 12233, MD EC–24, Research Triangle Park, NC 27709. (919) 541–1307. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: November 30, 2005. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–23794 Filed 12–7–05; 8:45 am] Dated: November 29, 2005. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–23793 Filed 12–7–05; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special VerDate Aug<31>2005 16:29 Dec 07, 2005 Jkt 208001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIAID. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Allergy and Infectious Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIAID. Division of Intramural Research, Board of Scientific Counselors. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Date: December 5–7, 2005. Time: December 6, 2005, 8 a.m. to 5 p.m. Agenda: To review and evaluate review of intramural laboratories. Place: National Institutes of Health, Building 50, 50 Center Drive, Conference Room 1227/1233, Bethesda, MD 20892. Time: December 6, 2005, 8 a.m. to 5 p.m. Agenda: To review and evaluate review of intramural laboratories. Place: National Institutes of Health, Building 50, 50 Center Drive, Conference Room 1227/1233, Bethesda, MD 20892. Time: December 7, 2005, 8 a.m. to 10:30 a.m. Agenda: To review and evaluate review of intramural laboratories. Place: National Institutes of Health, Building 50, 50 Center Drive, Conference Room 1227/1233, Bethesda, MD 20892. Contact Person: Kathryn C. Zoon, PhD, Acting Director, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Building 31, Room 4A30, Bethesda, MD 20892, 301–496–3006, kzoon@niaid.nih.gov. This meeting is being published less than 15 days prior to the meeting date because of an administrative error. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: November 30, 2005. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–23796 Filed 12–7–05:8:45am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting National Institutes of Health 73017 National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel. Hurricane Katrina Time Sensitive Review. Date: December 16, 2005. E:\FR\FM\08DEN1.SGM 08DEN1 73018 Federal Register / Vol. 70, No. 235 / Thursday, December 8, 2005 / Notices Time: 11 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Meenaxi Hiremath, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6101 Executive Blvd., Suite 220, MSC 8401, Bethesda, MD 20892, 301–402–7964, mh392g@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS) Dated: November 30, 2005. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–23800 Filed 12–7–05; 8:45am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Meeting Notice is hereby given of the first meeting of the Working Group on Chemical Information Resource Coordination under the National Library of Medicine’s (NLM) Board of Scientific Counselors, National Center for Biotechnology Information (NCBI). The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The mission of the Working Group on Chemical Information Resource Coordination is to advise the Board of Scientific Counselors, NCBI, on interactions with private sector information providers in the development of the PubChem database. PubChem is a publicly available database that includes information about the biological activities of chemical compounds, and is designed to facilitate more integrated access to these information resources for biomedical researchers. The working group will: (1) Establish a process for retrospective evaluation of the biomedical relevance of compounds entered into PubChem, (2) Ensure the provenance of the data (i.e., whether VerDate Aug<31>2005 16:29 Dec 07, 2005 Jkt 208001 private data are being improperly deposited into PubChem), (3) Ensuring the high quality of data in PubChem, (4) Monitoring the effect of PubChem on scientific progress, (5) Improving/ integrating interactions with commercial information providers, and (6) Avoiding unnecessary duplication with commercial information providers. This working group supports part of the National Institutes of Health’s Roadmap, called the Molecular Libraries Initiative. Name of Committee: Working Group on Chemical Information Resource Coordination. Date: December 19, 2005. Time: 9 a.m. to 4 p.m. Agenda: Discussion on the NLM/NCBI PubChem Database. Place: National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20894. Contact Person: David J. Lipman, MD, Director, National Center for Biotechnology Information, National Library of Medicine, NIH, Building 38A, Room 8N803, Bethesda, MD 20894, 301–496–2475. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The comment should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Dated: November 29, 2005. Nancy Middendorf, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–23792 Filed 12–7–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the Board of Regents of the National Library of Medicine. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Regents of the National Library of Medicine Extramural Programs Subcommittee. Date: February 6, 2006. Closed: 4 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, Building 38, Conference Room B, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Donald A.B. Lindberg, MD, Director, National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, 301– 496–6221, lindberg@mail.nih.gov. Name of Committee: Board of Regents of the National Library of Medicine Subcommittee on Outreach and Public Information. Date: February 7, 2006. Open: 7:30 a.m. to 8:45 a.m. Agenda: Outreach Activities. Place: National Library of Medicine, Building 38, Conference Room B, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Donald A.B. Lindberg, MD, Director, National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, 301– 496–6221, lindberg@mail.nih.gov. Name of Committee: Board of Regents of the National Library of Medicine. Date: February 7–8, 2006. Open: February 7, 2006, 9 a.m. to 4:30 p.m. Agenda: Program Discussion. Place: National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892. Closed: February 7, 2006, 4:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892. Open: February 8, 2006, 9 a.m. to 12 p.m. Agenda: Program Discussion. Place: National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Donald A.B. Lindberg, MD, Director, National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, 301– 496–6221, lindberg@mail.nih.gov. Name of Committee: Board of Regents of the National Library of Medicine Planning Subcommittee. Date: February 8, 2006. Open: 7:30 a.m. to 8:45 a.m. Agenda: Long-Range Planning. Place: National Library of Medicine, Building 38, Conference Room B, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Donald A.B. Lindberg, MD, Director, National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, 301– 496–6221, lindberg@mail.nih.gov. Any interested person may file written comments with the committee by forwarding E:\FR\FM\08DEN1.SGM 08DEN1

Agencies

[Federal Register Volume 70, Number 235 (Thursday, December 8, 2005)]
[Notices]
[Pages 73017-73018]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-23800]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel. Hurricane Katrina Time Sensitive Review.
    Date: December 16, 2005.

[[Page 73018]]

    Time: 11 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Meenaxi Hiremath, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6101 Executive 
Blvd., Suite 220, MSC 8401, Bethesda, MD 20892, 301-402-7964, 
mh392g@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: November 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-23800 Filed 12-7-05; 8:45am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.